文献速递主动脉疾病内脏/肾动脉与血管畸形

腹主动脉及胸腹主动脉瘤腔内修复术中覆盖副肾动脉的临床效果

Clinical effect of accessory renal artery coverage after endovascular repair of aneurysms in abdominal and thoracoabdominal aorta.
PubMed 文献 · J Vasc Surg · 2021-06-29

该系统综述与荟萃分析纳入10项回顾性非随机对照研究共1014例患者,评估标准EVAR或复杂主动脉瘤腔内修复中覆盖副肾动脉(ARA)对肾功能和死亡率的影响。结果显示覆盖ARA增加肾梗死风险,但未显著影响急性肾损伤、慢性肾衰竭或死亡。

要点

  • 覆盖副肾动脉增加肾梗死风险,标准EVAR组OR 93.3,复杂动脉瘤组OR 8.58。
  • 覆盖副肾动脉未显著增加急性肾损伤、慢性肾衰竭或死亡风险。
  • 六项研究中覆盖的副肾动脉平均直径<4 mm(范围2.7-3.4 mm),>4 mm的副肾动脉应考虑保留。

核心结论

  • 在标准EVAR或复杂主动脉瘤腔内修复患者中,覆盖直径<4 mm的副肾动脉与肾梗死风险增加相关。
  • 覆盖副肾动脉对术后早期及随访期间的肾功能或死亡率无显著临床影响。
  • 对于直径>4 mm的副肾动脉,应考虑保留。

研究设计与样本

  • 系统综述与荟萃分析,检索MEDLINE、EMBASE和Cochrane数据库2000年至2020年9月的英文文献。
  • 纳入10项回顾性非随机对照研究,共1014例患者(302例覆盖ARA vs 712例无ARA或未覆盖ARA)。
  • 采用PRISMA方法筛选文献,GRADE方法评估证据质量。
  • 患者分为覆盖ARA组和无ARA或未覆盖ARA组,每组含标准EVAR和复杂主动脉瘤腔内修复两个亚组。

主要发现

  • 标准EVAR亚组:覆盖ARA组与对照组急性肾损伤风险相似(OR 0.72,95%CI 0.21-2.51,I2=0%),随访期间慢性肾衰竭(OR 4.44,95%CI 0.46-42.61,I2=87%)和死亡(OR 0.91,95%CI 0.36-2.31,I2=0%)风险相似。
  • 标准EVAR亚组:覆盖ARA组肾梗死风险高于对照组(OR 93.3,95%CI 1.48-5869,I2=92%)。
  • 复杂动脉瘤修复亚组:覆盖ARA组与对照组急性肾损伤风险相似(OR 1.85,95%CI 0.61-5.64,I2=42%),随访期间慢性肾衰竭(OR 1.64,95%CI 0.88-3.07,I2=不适用)和死亡(OR 3.63,95%CI 0.14-96.29,I2=56%)风险相似。
  • 复杂动脉瘤修复亚组:覆盖ARA组肾梗死风险高于对照组(OR 8.58,95%CI 4.59-16.04,I2=0%)。
  • 六项研究中覆盖的ARA平均直径为<4 mm(范围2.7-3.4 mm),平均随访22.74个月(范围1-42个月)。

临床怎么用

  • 在标准EVAR或复杂主动脉瘤腔内修复中,覆盖直径<4 mm的副肾动脉需权衡肾梗死风险。
  • 对于直径>4 mm的副肾动脉,应考虑保留以降低肾梗死风险。
  • 覆盖副肾动脉后应关注肾梗死发生,但急性肾损伤、慢性肾衰竭和死亡风险未见显著增加。

局限性

  • 纳入研究均为回顾性非随机对照研究,证据等级有限。
  • 部分分析异质性较高(如标准EVAR组肾梗死I2=92%)。
  • 肾梗死OR值置信区间极宽(标准EVAR组95%CI 1.48-5869),提示结果不稳定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The aim of our systematic review and meta-analysis was to assess the effect of accessory renal artery (ARA) coverage on renal function in terms of acute kidney injury (AKI), renal infarction, chronic renal failure (CRF), and mortality in patients undergoing standard endovascular aortic aneurysm repair (EVAR) or endovascular repair of complex aneurysms. METHODS: An electronic search of the English language medical literature from 2000 to September 2020 was conducted using the MEDLINE, EMBASE, and Cochrane databases with the PRISMA (preferred reporting items for systematic reviews and meta-analyses) method for studies reporting on ARA management in patients undergoing endovascular repair of aneurysms in the abdominal and thoracoabdominal aorta. The patients were divided into two groups: group 1, patients with ARA coverage; and group 2, patients without an ARA or without coverage of the ARA. Each group included two arms, one of patients who had undergone standard EVAR and one of patients who had undergone endovascular treatment of a complex aortic aneurysm. The GRADE (grading of recommendations assessment, development, evaluation) approach was used to evaluate the quality of evidence and summary of the findings. The primary outcomes included the incidence of AKI, renal infarction, CRF, and mortality. RESULTS: Ten retrospective, nonrandomized, control studies were included in the systematic review reporting on 1014 patients (302 with a covered ARA vs 712 without an ARA or without ARA coverage). In six studies, the mean diameter of the covered ARA was <4 mm (range, 2.7-3.4 mm). The mean follow-up was 22.74 months (range, 1-42 months). In the standard EVAR subgroup, the risk of AKI (odds ratio [OR], 0.72; 95% confidence interval [CI], 0.21-2.51; I2 = 0%] in the early period, and CRF (OR, 4.44; 95% CI, 0.46-42.61; I2 = 87%) and death (OR, 0.91; 95% CI, 0.36-2.31; I2 = 0%) during follow-up were similar between groups 1 and 2. Only the risk of renal infarction was greater in group 1 than in group 2 (OR, 93.3; 95% CI, 1.48-5869; I2 = 92%). In the complex aneurysm repair subgroup, the risk of AKI (OR, 1.85; 95% CI, 0.61-5.64; I2 = 42%) in early period and CRF (OR, 1.64; 95% CI, 0.88-3.07; I2 = not applicable) and death (OR, 3.63; 95% CI, 0.14-96.29; I2 = 56%) during follow-up were similar between groups 1 and 2. Only the risk of renal infarction was greater for group 1 compared with group 2 (OR, 8.58; 95% CI, 4.59-16.04; I2 = 0%). CONCLUSIONS: ARA (<4 mm) coverage in patients undergoing standard EVAR or endovascular repair of complex aneurysms is associated with an increased risk of renal infarction. However, we found no clinical effects of ARA coverage on renal function or mortality in early postoperative and follow-up period. Preservation of an ARA >4 mm should be considered.

来源:J Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Spanos K, Nana P, Brotis AG, et al. Clinical effect of accessory renal artery coverage after endovascular repair of aneurysms in abdominal and thoracoabdominal aorta. J Vasc Surg. 2021. PMID: 34197943. doi:10.1016/j.jvs.2021.06.032

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。